10.000
−2,91%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -81.6% | -27.9% | 1 / 3 | -44.7% | -3.07 pp | -6.47 pp | +4.0% | 0.00 | 13.74 | 21,5 | −44,7% | 0,7 | −81,6% | 13.74 | 10.57 | +30,0% |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 10.000 (close price on 2026-10-19)EPS (TTM): 727,9
Financial charts
1.Revenue & growth
VND bn21,5Q2/26
1.Revenue & growth
VND bn21,5Q2/26
2.Profit & growth
VND bn0,69Q2/26
3.Profit mix (Penman)
VND bn11,3Q2/26
4.Margins & cost structure
%21.0%Q2/26
5.Returns & cash cycle
% · days4.7%Q2/26
6.Earnings quality & cash
VND bn24,8Q2/26
7.Asset structure
VND bn243Q2/26
8.Funding & debt health
VND bn · times243Q2/26
9.Revenue backlog
VND bn1,42Q2/26
10.Valuation
times · %13,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %56Q2/26
Adjusted EPS growth, latest quarter
-81.6%
Average adjusted EPS growth, 3 quarters
-27.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26